EYPT
EYPT
NASDAQ · Pharmaceuticals

Eyepoint Inc

$13.34
+0.14 (+1.06%)
As of May 9, 1:37 AM ET ·
Analyst Consensus
Strong Buy
18
Analysts
High
Coverage
Buy 17 94%
Hold 1 6%
Sell 0 0%
Price Target
Analyst Price Target -31.0% upside
Low Target $6.71
Average Target $9.21
High Target $14.14
Current Price $13.34
Current
$13.34
Target
$9.21
$6.71 $9.21 avg $14.14
Scenario Analysis
Bear Case
$6.71
-49.7%
Low target
Base Case
$9.21
-31.0%
Avg target
Bull Case
$14.14
+6.0%
High target
Risk/Reward
0.1x
Unfavorable
Price in Context
52-Week High
$19.11
-30.2% from high
52-Week Low
$5.30
+151.7% from low
Target vs 52W High
$9.21
-51.8% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
RDY
Dr. Reddy's Laboratories
Hold 45 51% +0.0%
LLY
Eli Lilly and Co.
Strong Buy 39 77% $1,330.33 +40.3%
JNJ
Johnson & Johnson
Buy 32 63% $299.55 +35.3%
MRK
Merck & Co. Inc.
Buy 35 71% $159.27 +43.0%
PFE
Pfizer Inc.
Hold 36 44% $33.90 +32.0%
BMY
Bristol-Myers Squibb Co
Hold 36 42% $174.50 +210.7%
ZTS
Zoetis Inc
Buy 25 60% $209.87 +153.4%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -28.6%